Patent expiry of key drugs to open up extra market space for Indian pharma manufacturers
The patent expiry of key drugs in 2025-26 will open up additional market space for Indian manufacturers of generics and ...
RFK Jr’s call to ban TV drug advertisements revives talks of price transparency
Robert F. Kennedy Jr., President-elect Donald Trump‘s nominee to lead the Department of Health and Human Services, wants to ...
Biden adds weight loss drugs to Medicare price negotiations
Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.
WPLG8d
Ozempic, Wegovy and other drugs are among 15 selected for Medicare's price negotiations
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
USA Today16d
Ozempic, Trulicity among Medicare's priciest drugs, report finds
The drugs are Eliquis, Jardiance ... Retail drugs that have no generic equivalent and have been on the market for at least seven years can be eligible for negotiation. Biologic drugs, which ...
news.bloomberglaw16d
Medicare Drug Price Explanations Shed Some Light on Future Talks
The agency considered the clinical benefit of a drug in the context of its therapeutic alternatives ... pointing to alternatives for Bristol-Myers Squibb’s blood thinner Eliquis, which included ...
Business Insider22d
Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker
Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda, the ...